Zacks Investment Research
19 Jun 2026, 10:36 UTC · 3h ago
Methode (MEI) Stock Jumps 21.2%: Will It Continue to Soar?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
19 Jun 2026, 10:36 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Methode (MEI) shares rallied 21.2% in the last trading session on high volume. — A sudden double-digit price spike on high volume indicates strong immediate bullish sentiment or a significant catalyst for the specific ticker.
+0.40Methode (MEI) is expected to report a quarterly loss of $0.11 per share and an 11% year-over-year revenue decline. — Projected losses and shrinking top-line revenue are fundamental negatives that could reverse the recent price rally.
-0.30Amphenol (APH) has returned 30.9% over the past month and maintains a Zacks Rank #2 (Buy). — Strong momentum and a positive analyst rank suggest sustained investor confidence in the stock's upward trajectory.
+0.20Which stocks this story touches
Continue reading
6 related stories
Search tags
Stock returned 30.9% over the past month and holds a Zacks Rank #2 (Buy) with strong expected EPS growth.
Shares rallied 21.2% due to strong demand for off-road lighting and data center solutions, despite expectations of a quarterly loss.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
